Remove Arrhythmia Remove Pericarditis Remove Research
article thumbnail

Biosense Webster Submits Application to U.S. FDA Seeking Approval of the VARIPULSE Platform for the Treatment of Paroxysmal Atrial Fibrillation

DAIC

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTec h i , announced the submission of the VARIPULSE Platform for Premarket Approval Application (PMA) to the U.S. 6 Learn more about Biosense Webster's PFA research and clinical evidence here. Food & Drug Administration ( FDA ).

article thumbnail

Vaccine myocarditis update from Korea

Dr. Anish Koka

While US public health authorities have been convinced from the very beginning about how safe and effective the new vaccines are, researchers in other countries with far smaller budgets have been testing that theory.

article thumbnail

Inferior ST elevation with reciprocal change: which of these 4 patients has Occlusion MI?

Dr. Smith's ECG Blog

First Troponin I was <2 and peak was 8, echo showed subtle apical lateral hypokinesis, CRP was elevated, and patient was discharged with a diagnosis of regional pericarditis. In this case, there would be evolution, but the evolution would be typical of pericarditis (if the diagnosis of pericarditis was accurate!!

article thumbnail

A COVID19 vaccine exemption letter

Dr. Anish Koka

In August, the CDC reported 29 cases of pericarditis, including five in persons with a history of pericarditis after mRNA COVID-19 vaccine ; 10 Importantly, the Novovax vaccine is a protein based vaccine that was hoped to not be associated with myocarditis as was noted with the mRNA vaccines.